The UK is undertaking the world’s first clinical trial that aims to determine the safety and effects of using different vaccines for the first and second dose. The COVID-19 Heterologous Prime Boost study (or ‘Com-Cov’), which is backed by £7m of government funding and run by the National Immunisation Schedule Evaluation Consortium (NISEC) across eight [ ]
The post UK to undertake world-first COVID-19 alternating vaccine dose study appeared first on Health Europa.
Saturday 6 March 2021
healtheuropa - 30 days ago
UK to undertake world-first COVID-19 alternating vaccine dose study
